Reverse haplotyping: taking full advantage of 25% risk testing for the 50% at-risk parent in Huntington’s disease

Emilia K Bijlsma, Tamara T Koopmann, Susanne T de Bot, Monique Losekoot

Open source

DOI
10.1136/jmg-2026-111509
Published
2026-04-09
Container
Journal of Medical Genetics
Publisher
BMJ
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/jmg-2026-111509,
  title = {Reverse haplotyping: taking full advantage of 25\% risk testing for the 50\% at-risk parent in Huntington’s disease},
  author = {Emilia K Bijlsma and Tamara T Koopmann and Susanne T de Bot and Monique Losekoot},
  year = {2026},
  journal = {Journal of Medical Genetics},
  doi = {10.1136/jmg-2026-111509},
  url = {https://doi.org/10.1136/jmg-2026-111509}
}

RIS

TY  - JOUR
TI  - Reverse haplotyping: taking full advantage of 25% risk testing for the 50% at-risk parent in Huntington’s disease
AU  - Emilia K Bijlsma
AU  - Tamara T Koopmann
AU  - Susanne T de Bot
AU  - Monique Losekoot
PY  - 2026
JO  - Journal of Medical Genetics
DO  - 10.1136/jmg-2026-111509
UR  - https://doi.org/10.1136/jmg-2026-111509
ER  - 

APA

Bijlsma, E. K., Koopmann, T. T., Bot, S. T. D., & Losekoot, M. (2026). Reverse haplotyping: taking full advantage of 25% risk testing for the 50% at-risk parent in Huntington’s disease. Journal of Medical Genetics. https://doi.org/10.1136/jmg-2026-111509

Source records